The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Amgen
SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bristol-Myers Squibb; Ferring; Janssen; Johnson & Johnson; Nucleix; Olympus; pacific edge; Photocure; QED Therapeutics; Seagen; Spectrum Pharmaceuticals
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Clint Cary
No Relationships to Disclose
 
Timothy A. Masterson
No Relationships to Disclose
 
Lawrence Einhorn
No Relationships to Disclose
 
Stephen A. Boorjian
Consulting or Advisory Role - ArTara Therapeutics; FerGene; Ferring; Sanofi
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Ipsen; Merck; Merck KGaA; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Eisai; Novartis; Pfizer
 
Anne K. Schuckman
Honoraria - Photocure
Consulting or Advisory Role - Fergene; Gerson Lehrman Group; Photocure
Speakers' Bureau - Photocure
Travel, Accommodations, Expenses - Photocure
 
Alan So
No Relationships to Disclose
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Asieris Pharmaceuticals; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; EMD Serono; Ferring; H3 Biomedicine; Janssen Oncology; MDxHealth; Merck; Roche Canada; Sanofi; Urogen pharma
Speakers' Bureau - Pfizer; TerSera
Research Funding - GenomeDx; GlaxoSmithKline; iProgen; Sitka
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Sanofi
Other Relationship - Sanofi
 
Aditya Bagrodia
No Relationships to Disclose
 
Eila C. Skinner
Research Funding - Genentech/Roche
 
Mehrdad Alemozaffar
No Relationships to Disclose
 
Timothy C. Brand
No Relationships to Disclose
 
Scott E. Eggener
Consulting or Advisory Role - Francis Medical; InSightec; Profound Medical; Sophiris Bio
Speakers' Bureau - Janssen
Travel, Accommodations, Expenses - InSightec; Janssen Biotech; Sophiris Bio
(OPTIONAL) Uncompensated Relationships - Steba Biotech
 
Phillip M. Pierorazio
No Relationships to Disclose
 
Kelly Lynn Stratton
Honoraria - Bayer; Dendreon (Inst); Oakstone Publishing; Sun Pharma
Consulting or Advisory Role - AMRO Pharma (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Large Urology Group Practice Association (Inst); Myriad Genetics (Inst); Sanofi (Inst)
Speakers' Bureau - Bayer
Research Funding - Advantage Pharmaceuticals (Inst); Anchiano (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); EMD Serono (Inst); Ferring (Inst); Genentech (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Myriad Genetics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Dendreon; Dendreon (Inst); Myriad Genetics
 
Lucia Nappi
Honoraria - Astellas Pharma; Ipsen; Pfizer
Patents, Royalties, Other Intellectual Property - IVERMECTIN ANALOGUE COMPOUND THERAPEUTICS FOR HEAT SHOCK PROTEIN-27 (HSP27) INHIBITION, METHODS AND USES ASSOCIATED THEREWITH provisional number: 62/756,707
Travel, Accommodations, Expenses - Pfizer
 
Craig R. Nichols
No Relationships to Disclose
 
Brian Hu
No Relationships to Disclose